Drug Delivery & Formulation 2019

DESCRIPTION

On 19 & 20 September 2019, Munich (Germany) will host the BioTech Pharma Summit: Drug Delivery & Formulation 2019 conference. This year’s event will bring together leaders and senior industry experts in formulation, delivery and product development. Presentations will assess recent technological innovations and discuss their impact on product improvement and patient experience.

Over 200+ delegates representing global pharmaceutical organisations, leading biotech companies and internationally renowned academic institutions

Drug delivery systems have been gaining importance in the last few years. Such systems can be easily developed and are capable of promoting the modified release of the active ingredients in the body. The opportunities and challenges of nanomedicines in drug delivery from synthetic/natural sources to their clinical applications will also be discussed. This year, at the DDF Summit in Munich, we will see innovation and breakthroughs at all levels of drug and formulation development.

The Drug Delivery & Formulation 2019 features never-before-heard case studies focusing on the industry’s most urgent needs for improving solubility and therapeutic performance.

The BioTech Pharma Summit: Drug Delivery & Formulation 2019 provides drug delivery and specialty pharmas with a platform to present their technologies and get the latest insights on what the delivery and formulation needs are and presents a strategic level program for pharma and business development professionals with a thorough overview of the latest drug delivery technologies available along with an update on deals and opportunities to improve therapies and extend the life cycle of a drug.

KEY PRACTICAL LEARNING POINTS

  • Opportunities and Challenges in Drug Development
  • Advances in Drug Delivery
  • Small and Large Molecule Drug Formulation
  • Sustained delivery and formulation of biologics
  • Targeted and controlled release technologies and nanoparticles
  • Formulation of novel molecule
  • Less traditional delivery routes
  • The potential of nanotechnology for better deliverability
  • Reformulation and biosimilars
  • Developing nano-enabled medicines
  • The latest controlled released technologies
  • Drug-Device compatibility
  • Optimizing formulations for continuous manufacturing
  • Drug Delivery Devices
  • Biopharmaceutical Drug Product Robustness Studies
  • User friendly technologies for improving patient convenience and compliance
  • Bioanalysis and Stabilisation
  • The future of Drug Delivery and Formulation

WHO SHOULD ATTEND?

The BioTech Pharma Summit (EPM Group) are exclusive events consisting of world-class keynote addresses and presentations designed specifically for senior level attendees from research & academic institutions, clinical research institutions and hospital laboratories as well as major pharmaceutical and biotech companies based Worldwide. Delegates typically include CEOs, VPs, Drug developers, Academics and Researchers, CROs, Evangelists, Scientists and Medical Doctors of:

  • Formulation Science
  • Biologics Development
  • Drug Delivery
  • Bioformulations Development
  • Solid State Characterisation
  • Formulation Characterisation
  • Sustained Delivery
  • Analytical Investigations
  • Drug Delivery Innovation
  • Stability Sciences
  • Device R&D
  • Device Design
  • Formulation Development
  • Pre-formulation
  • Drug Delivery Innovation
  • Bioanalytical Sciences
  • Delivery Device Development
  • Drug Delivery Design
  • Small Molecule Development
  • Delivery Technologies
  • Nanotechnology
  • Combination Product Development
  • Device Strategy
  • Device Engineering

Professor at University of Geneva, Switzerland
Scientist II at AstraZeneca
Director of Drug Product, Formulation & Stability at Immunocore
Director Formulation at Lonza
Head of Formulation Development for Gene Therapy and Protein Modalities at Takeda
Director Liquid Formulation R&D at Merck KGaA
Formulation Team leader at Ipsen
Head and Scientific Director, Drug product development at The Janssen Pharmaceutical Companies
Department Head Pharma and Microbial Services at Nelson Labs NV
Chief Scientific Officer at Nanomerics
Senior Scientist I at AbbVie
Analytical Project Leader at Novartis
Senior Director, R&D Alliance Management at Sanofi
Senior Consultant, European Thought Leadership at IQVIA
Lab head Drug Product development of Biologics at Sanofi
Chief Operating Officer at Leukocare AG
CSO at Thiomatrix Forschungs- Beratungs GmbH
Team Head Pharmaceutical Development Early Phase at Novartis
Early-Bird Pass
1,695
Buy Ticket

Full-Access to all Sessions

Coffee Breaks/Lunches

Gala Dinner

Unique 1-on-1 meetings

Premium Pass
3,000
Buy Ticket

Full-Access to all Sessions

Coffee Breaks/Lunches

2-night Accommodation

Airport Pick-up/Drop-off

Academic Pass
600
Buy Ticket

Full-Access to all Sessions

Coffee Breaks/Lunches

Exhibition Package
3,550
Buy Ticket

3m2 exhibition space

Full-Access to all Sessions

2 Delegates Free Admission

Gala Dinner


Event Details
Sponsors